Skip to main content
. 2020 Mar 30;8:40. doi: 10.1186/s40478-020-00913-w

Table 1.

Characteristics of patients with spinal cord astrocytoma in this study

Total Total (Grade II–IV) P-value
H3 wildtype H3 K27M-mutant
Number 83 48 35
Age (year) Median 31(6–63) 30(6–63) 35(9–52) n.s
Gender n.s
male 49(59%) 31(65%) 18(51%)
female 34(41%) 17(35%) 17(49%)
Histological grade 0.0068
II 51(61%) 37(77%) 14(40%)
III 20(24%) 6(13%) 14(40%)
IV 12(14%) 5(10%) 7(20%)
Location n.s
C 29(35%) 19(40%) 10(29%)
C-T 13(16%) 6(13%) 7(20%)
T 34(41%) 19(40%) 15(43%)
T-L 7(8%) 4(8%) 3(9%)
Resection < 0.0001
GTR 50(60%) 38(79%) 12(34%)
STR 16(19%) 6(13%) 10(29%)
OB 17(20%) 4(8%) 13(37%)
Radio n.s
yes 53(64%) 30(63%) 23(66%)
no 18(22%) 12(25%) 6(17%)
unknown 12(14%) 6(13%) 6(17%)
Chemo 0.0484
yes 23(28%) 10(21%) 13(37%)
no 47(57%) 32(67%) 15(43%)
unknown 13(16%) 6(13%) 7(20%)
IDH n.s
wildtype 58(70%) 33(69%) 25(71%)
mutant 0(0%) 0(0%) 0(0%)
unknown 25(30%) 15(31%) 10(29%)
TERT promoter n.s
wildtype 45(54%) 24(50%) 21(60%)
mutant 13(16%) 9(19%) 4(11%)
unknown 25(30%) 15(31%) 10(29%)
BRAF V600E 0.0141
wildtype 50(60%) 26(54%) 24(69%)
mutant 7(8%) 7(15%) 0(0%)
unknown 26(31%) 15(31%) 11(31%)
Ki-67 < 0.0001
< 10% 44(53%) 37(63%) 7(20%)
≥10% 46(55%) 18(33%) 28(80%)
unknown 3(4%) 3(4%) 0(0%)
Survival (Median OS, months) 40.13 Und 20.7 < 0.0001

C cervical vertebrae, C-T cervicothoracic vertebrae, T thoracic vertebrae, T-L thoracolumbar vertebrae, GTR gross total resection, STR subtotal resection, OB open biopsy, Radio Radiotherapy, Chemo Chemotherapy

Significant P-values are indicated in bold text